Investors in AstraZeneca PLC and Capri Holdings Limited are being urged to participate in class action lawsuits due to substantial financial losses. Kahn Swick & Foti, LLC has reminded AstraZeneca investors with losses exceeding $100,000 of the lead plaintiff deadline for their lawsuit. Similarly, Capri Holdings investors with significant losses are also being alerted to the opportunity to lead a class action. Other companies mentioned include Symbotic Inc., MGP Ingredients, Inc., and Sun Communities, Inc., with respective law firms encouraging their investors to inquire about their rights in ongoing class action lawsuits. Additionally, a proposed class action against Caribou Biosciences highlights a 26% drop in share price attributed to misleading claims about its lead therapy's efficacy and a poor financial outlook. Cassava Sciences, Inc. is also facing a class action lawsuit for substantial investor losses.